Mark Legault

774 total citations
12 papers, 634 citations indexed

About

Mark Legault is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, Mark Legault has authored 12 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 5 papers in Cognitive Neuroscience and 2 papers in Molecular Biology. Recurrent topics in Mark Legault's work include Neuroscience and Neuropharmacology Research (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Obsessive-Compulsive Spectrum Disorders (2 papers). Mark Legault is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Obsessive-Compulsive Spectrum Disorders (2 papers). Mark Legault collaborates with scholars based in Canada, United States and South Africa. Mark Legault's co-authors include Roy A. Wise, Pierre-Paul Rompré, Louis‐Éric Trudeau, Florence Marteau, Dan J. Stein, Eric Hollander, Naomi Fineberg, Marie‐Josée Bourque, Fannie St-Gelais and Patrice Congar and has published in prestigious journals such as Journal of Neuroscience, Neuroscience and European Journal of Neuroscience.

In The Last Decade

Mark Legault

12 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Legault Canada 8 436 286 180 91 58 12 634
Aude Belin‐Rauscent United Kingdom 13 552 1.3× 218 0.8× 206 1.1× 114 1.3× 68 1.2× 17 678
Sietse Jonkman United Kingdom 11 516 1.2× 309 1.1× 254 1.4× 56 0.6× 61 1.1× 15 729
Abhiram Pushparaj Canada 13 452 1.0× 252 0.9× 295 1.6× 61 0.7× 31 0.5× 22 775
Stéphanie Alaux‐Cantin France 11 443 1.0× 274 1.0× 209 1.2× 105 1.2× 61 1.1× 13 804
Emanuele Seu Italy 15 370 0.8× 289 1.0× 155 0.9× 45 0.5× 118 2.0× 16 694
Zhifeng Zhou United States 13 297 0.7× 232 0.8× 326 1.8× 89 1.0× 37 0.6× 20 839
Lauren M. Burgeno United States 9 422 1.0× 181 0.6× 231 1.3× 65 0.7× 84 1.4× 11 671
Yolanda Peña‐Oliver United Kingdom 11 309 0.7× 174 0.6× 93 0.5× 54 0.6× 50 0.9× 14 448
Jesse Wood United States 12 342 0.8× 279 1.0× 140 0.8× 127 1.4× 62 1.1× 14 562
Chiara Giuliano United Kingdom 15 488 1.1× 181 0.6× 199 1.1× 163 1.8× 69 1.2× 24 679

Countries citing papers authored by Mark Legault

Since Specialization
Citations

This map shows the geographic impact of Mark Legault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Legault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Legault more than expected).

Fields of papers citing papers by Mark Legault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Legault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Legault. The network helps show where Mark Legault may publish in the future.

Co-authorship network of co-authors of Mark Legault

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Legault. A scholar is included among the top collaborators of Mark Legault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Legault. Mark Legault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Metelitsa, Andrei I., et al.. (2023). A Practical Guide to Advanced Topical Drug Delivery Systems in Dermatology.. PubMed. 28(5). 5–11. 1 indexed citations
2.
Lachaîne, Jean, et al.. (2011). Economic Evaluation of the Impact of Memantine on Time to Nursing Home Admission in the Treatment of Alzheimer Disease. The Canadian Journal of Psychiatry. 56(10). 596–604. 17 indexed citations
3.
Hollander, Eric, Dan J. Stein, Naomi Fineberg, Florence Marteau, & Mark Legault. (2010). Quality of Life Outcomes in Patients With Obsessive-Compulsive Disorder. The Journal of Clinical Psychiatry. 71(6). 784–792. 82 indexed citations
4.
Fineberg, Naomi, Dan J. Stein, Mark Legault, Florence Marteau, & Eric Hollander. (2010). P.4.a.001 Quality of life outcomes in obsessive-compulsive disorder: relationship to treatment response and symptom relapse. European Neuropsychopharmacology. 20. S520–S521. 1 indexed citations
5.
Legault, Mark, et al.. (2009). Escitalopram in clinical practice in Greece: treatment response and tolerability in depressed patients. Expert Opinion on Pharmacotherapy. 10(6). 937–945. 6 indexed citations
6.
Chokka, Pratap & Mark Legault. (2008). Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial. Depression and Anxiety. 25(12). E173–E181. 8 indexed citations
7.
St-Gelais, Fannie, Mark Legault, Marie‐Josée Bourque, Pierre-Paul Rompré, & Louis‐Éric Trudeau. (2004). Role of Calcium in Neurotensin-Evoked Enhancement in Firing in Mesencephalic Dopamine Neurons. Journal of Neuroscience. 24(10). 2566–2574. 59 indexed citations
8.
Legault, Mark, Patrice Congar, Michel François, & Louis‐Éric Trudeau. (2002). Presynaptic action of neurotensin on cultured ventral tegmental area dopaminergic neurones. Neuroscience. 111(1). 177–187. 31 indexed citations
10.
Legault, Mark, Pierre-Paul Rompré, & Roy A. Wise. (2000). Chemical Stimulation of the Ventral Hippocampus Elevates Nucleus Accumbens Dopamine by Activating Dopaminergic Neurons of the Ventral Tegmental Area. Journal of Neuroscience. 20(4). 1635–1642. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026